期刊文献+

糖皮质激素对淤胆型药物性肝病的疗效 被引量:5

Efficacy of glucocorticoid for cholestatic liver disease
暂未订购
导出
摘要 目的比较激素及非激素在治疗严重的淤胆型药物性肝病(DILD)中的作用。方法淤胆型DILD诊断依据为Za-kim分类标准,疗效标准为治疗后血清胆红素降至正常,疗效的显著性比较用t检验进行分析。结果1996~2006年10年间收治的严重淤胆型DILD78例,依据是否应用激素治疗将其分为激素治疗组及非激素治疗组。激素治疗组以激素使用前的总胆红素为基数,非激素治疗组以入院时的总胆红素为基数;以住院期间平均每天总胆红素升高或下降占基数的百分比表示治疗反应。激素治疗组为52例,治愈率为92.31%。非激素治疗组为26例,治愈率为69.23%,在治疗有效的病例中,激素治疗组开始治疗时总胆红素为(354.36±137.68)μmol/L,比非激素治疗组的(254.77±74.51)μmol/L明显为高(P<0.05)。激素治疗组总胆红素每天平均下降速率为3.56%±2.11%,明显快于非激素治疗组的2.12%±1.02%(P<0.05)。结论对于胆汁淤积型DILD,糖皮质激素可以有效减轻淤胆症状,使黄疸消退。 To compare the efficacy of steroid and non-steroid therapy in the severe cholestatic drug induced liver disease (DILD). Methods Za-kim class criteria was used as the diagnostic criteria, Serum bilirubin de-scending to normal level was considered as cure. T-test was used to study the efficacy. Results 78 patients who had been diagnosed as cholestatic DILD since 1996 to 2006 in PUMC hospital were analysed. They were di-vided into steroid and non-steroid treatment groups according to whether they received steroid therapy. The steroid group had 52 patients, 92.31% of whom were cured, compared with 69.23% efficacy in 26 patients in an-other group. The average descending rate of total bilirubin per day in the steroid treatment group is 3.56%±2.11%, which is also higher than that in the non-steroid group which is 2.12%±1.02% (P〈0.05). Conclusions Glucocorticoid is effective to alleviate the symptoms of cholestasis and to reduce the serum total bilirubin in the treatment of the cholestatic DILD.
出处 《临床药物治疗杂志》 2007年第3期30-32,共3页 Clinical Medication Journal
关键词 药物性肝病 糖皮质激素 胆汁淤积 Drug Induced Liver Disease Glucocorticoid Cholestasis
  • 相关文献

参考文献5

  • 1McRae CA,Agarwal K,Mutimer D,et al.Freeman hospital liver unit,newcastle upon tyne hospitals trust,Newcastle,UK.Hepati-tis associated with Chinese herbs[].Eur J GastroenterolHepatol.2002
  • 2Larrey D.Epidermiology and individual susceptibility to adverse drug reactions affecting the liver[].Seminars in Liver Disease.2002
  • 3Zekim D,ThomasL D,Hepatology.3rd ed[]..1996
  • 4Azerow SK,Abdi MS,Lewis JH.Drug-induced liver disease2004[].Current Opinion.2005
  • 5Benichou C.Criteria Of drug induced liver disease:report Of an intenational consensus meetmg[].Hepatology.1990

同被引文献28

  • 1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:397
  • 2陆伦根.胆汁淤积的发生机制和诊治策略[J].胃肠病学,2005,10(3):188-191. 被引量:12
  • 3陆玮婷,李军,欧宁,陈念,刘源,郭雪江,王瑞云,鲁翔,黄峻.276例药物性肝损伤的病因和临床表现分析[J].中华肝脏病杂志,2006,14(11):832-834. 被引量:61
  • 4诸葛建琳,傅浪高,徐玲,吴云辉.前列地尔联合腺苷蛋氨酸治疗肝衰竭102例临床疗效观察[J].浙江实用医学,2007,12(1):25-25. 被引量:6
  • 5Kaplowitz N. Drug-induced liver disease: implications for drug development and regulation [ J ]. Drug Saf, 2001,24 (7) : 483-490.
  • 6Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis [ J ]. Hepatology, 1997,26 ( 3 ) :664-669.
  • 7Benichou C. Criteria of drug-induced fiver disorders. Report of an international consensus meeting [ J ]. J Hepatol, 1990, 11 : 272 -276.
  • 8Ikeda T. Drug-induced liver injury [ J ]. Nippon Yakudgaku Zasshi ,2006,127:454-459.
  • 9Andrade R J, Lucena MI, Fernandez MC, et al. Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period[ J]. Gastroenterology, 2005,129:512-521.
  • 10Naga Chalasani, Robert J, Fontana, et al. Causes, Clinical Features,and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States[ J]. Gastroenterology, 2008,135 : 1924-1934.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部